ImmuneModerate Evidence

Thymosin Alpha-1

Also known as: Tα1, Thymalfasin, Zadaxin

Synthetic 28-amino acid peptide that modulates immune function through T-cell enhancement and cytokine regulation.

Evidence

Moderate

FDA status

Not FDA-approved

Source

Synthetic 28-amino acid peptide

Overview

Synthetic 28-amino acid peptide that modulates immune function through T-cell enhancement and cytokine regulation.

Mechanism of Action

Acts via TLRs on dendritic cells to activate NF-κB and JNK/p38/AP1 pathways, enhances T-cell differentiation and Th1 cytokine production (IFN-γ, IL-2), activates dendritic cells and NK cells, upregulates regulatory T-cells, downregulates pro-inflammatory cytokines.

What research has looked at

Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.

  • Enhances cellular and humoral immunity
  • Activates T-cells and natural killer cells
  • Reduces viral load in chronic infections
  • Balances immune response (upregulates when low, downregulates when excessive)
  • Anti-inflammatory in autoimmune conditions

Researched for

Research topics, not approved uses.

Chronic hepatitis B and CHIV/AIDSImmunodeficiency statesChronic infectionsAutoimmune diseases

How Gabriel approaches peptides

Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. Thymosin Alpha-1 isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.

Read the peptide therapy guide

Research & Evidence

Evidence Level
Moderate
Studies

Clinical trials, mainly in chronic hepatitis B

Summary

Approved as thymalfasin (Zadaxin) in a number of countries outside the US, mainly for chronic hepatitis B. Trial results for other uses are mixed. It is not FDA-approved.

Safety Information

Potential Side Effects

  • •Injection site reactions
  • •Mild flu-like symptoms
  • •Headache (rare)

Contraindications

  • Pregnancy
  • Breastfeeding

Interactions

  • ⚠May enhance other immunotherapies

Quick Facts

CategoryImmune
SourceSynthetic 28-amino acid peptide
StatusApproved in some countries outside the US; not FDA-approved